Succesful treatment of chronic hepatitis C virus infection with daclatasvir and asunaprevir in a transfusion dependent thalassaemia patient
Köklü, H.; Köklü, S.; Ozturk, O.; Aksoy, E.K.; Tseveldorj, N.
Acta Gastro-Enterologica Belgica 79(4): 501-502
2016
ISSN/ISBN: 1784-3227 PMID: 28209112 Document Number: 691078
Document emailed within 1 workday
Related Documents
Hamidah, A.; Yong, J.F.; Zulkifli, H.I.; Jamal, R. 2002: Treatment of chronic hepatitis C virus infection with interferon alfa and ribavirin: sustained response in two patients with transfusion dependent thalassaemia Medical Journal of Malaysia 57(3): 353-356Mazumder, M.; Sengupta, B.; De, M.; Lahiri, P.; Bhattacharya, D.K. 1993: Immunosurveillance of transfusion dependent thalassaemia and hepatitis B vaccination Journal of the Association of Physicians of India 41(6): 342-344
Dahlui, M.; Hishamshah, M.I.; Rahman, A.J.A.; Aljunid, S.M. 2009: Quality of life in transfusion-dependent thalassaemia patients on desferrioxamine treatment Singapore Medical Journal 50(8): 794-799
Tung, H.-D.; Lu, S.-N.; Lee, C.-M.; Wang, J.-H.; Chen, T.-M.; Hung, C.-H.; Huang, W.-S.; Changchien, C.-S. 2002: Antiviral treatment responses in patients with chronic hepatitis C virus infection evaluated by a third generation anti-hepatitis C virus assay Journal of Viral Hepatitis 9(4): 304-308
Baba, T.; Makino, R.; Shibata, M.; Harada, E.; Mitamura, K. 1997: Interferon treatment for hepatitis G virus infection in patients with chronic hepatitis C Nihon Rinsho. Japanese Journal of Clinical Medicine 55(3): 625-630
Teuber, G.; Dienes, H.P.; Meyer zum Büschenfelde, K.H.; Gerken, G. 1995: Hepatitis B virus superinfection in a patient with chronic hepatitis C receiving alpha-interferon treatment Hepato-Gastroenterology 42(2): 189-191
Gil Grande, R.; Gómez Pellico, C.; González García, R.; de Ramón Garrido, E.; Solís Villa, J.; Izquierdo, M.; Ramis, M. 1980: Autoimmune hemolytic anemia in a patient with chronic hepatitis B virus infection Revista Clinica Espanola 159(3): 217-220
Sharmin, T.; Mollah, A.H.; Morshed, A.A.; Chowdhury, M.K. 2018: Thyroid Status in Children with Transfusion Dependent Hb-E β-Thalassaemia Mymensingh Medical Journal: Mmj 27(2): 348-357
Pippard, M.J.; Letsky, E.A.; Callender, S.T.; Weatherall, D.J. 1978: Prevention of iron loading in transfusion-dependent thalassaemia Lancet 1(8075): 1178-1181
Ong, C.K.; Lim, S.L.; Tan, W.C.; Ong, E.E.; Goh, A.S. 2008: Endocrine complications in transfusion dependent thalassaemia in Penang Hospital Medical Journal of Malaysia 63(2): 109-112
Urbánek, P. 2013: Treatment of chronic hepatitis C virus infection at the beginning of a new era Vnitrni Lekarstvi 59(7): 612-617
Kaya, S.çu. 2008: Treatment of chronic hepatitis C virus infection in hemodialysis patients Mikrobiyoloji Bulteni 42(3): 525-534
Saravanan, S.; Velu, V.; Nandakumar, S.; Madhavan, V.; Shanmugasundaram, U.; Murugavel, K.G.; Balakrishnan, P.; Kumarasamy, N.; Solomon, S.; Thyagarajan, S.P. 2009: Hepatitis B virus and hepatitis C virus dual infection among patients with chronic liver disease Journal of Microbiology Immunology and Infection 42(2): 122-128
Hrycewycz, N.; Sandres, K.; Barange, K.; Pascal, J.P.; Izopet, J.; Payen, J.L. 2001: Eradication of hepatitis C virus after 3 months of interferon and ribavirin treatment in an a interferon non-responder patient with chronic hepatitis C Gastroenterologie Clinique et Biologique 25(11): 1041-1042
Annicchiarico, B.E.; Siciliano, M.; Gasbarrini, A. 2012: Chronic hepatitis C virus infection: clinical picture and treatment possibilities Giornale Italiano di Nefrologia: Organo Ufficiale Della Societa Italiana di Nefrologia 29(Suppl 54): S103-S108
Korba, B.E.; Cote, P.J.; Menne, S.; Toshkov, I.; Baldwin, B.H.; Wells, F.V.; Tennant, B.C.; Gerin, J.L. 2004: Clevudine therapy with vaccine inhibits progression of chronic hepatitis and delays onset of hepatocellular carcinoma in chronic woodchuck hepatitis virus infection Antiviral Therapy 9(6): 937-952
Fernández-Yunquera, A.; Rincón, D.; Salcedo, M.; Bañares, R. 2013: Update on the use of direct-acting antiviral agents for the treatment of chronic hepatitis C virus infection Revista Espanola de Quimioterapia: Publicacion Oficial de la Sociedad Espanola de Quimioterapia 26(3): 189-192
Cristiane A. Nogueira, V.; Edelman, D.C.; Nogueira, C.M.; Nogueira, S.A.; Sergio, H. M.Coelho; Abrahao, L.Jr, J.; Vanderboght, B.; Lambert, J.S.; Constantine, N.T. 2002: Hepatitis C Virus Transfusion-Transmitted Infection in Brazilian Cardiac Surgery Patients Clinical Laboratory 48(9-10): 529-533
Chuang, W.L.; Chang, W.Y.; Lu, S.N.; Lin, Z.Y.; Chen, S.C.; Hsieh, M.Y.; Wang, L.Y.; Wu, C.C.; Chang, S.F.; Chow, T.Y. 1987: Hepatitis D virus infection in patients with chronic hepatitis B virus infection Gaoxiong Yi Xue Ke Xue Za Zhi 3(2): 121-127
Tanaka, E. 1997: GB virus C/hepatitis G virus infection in patients with chronic non-B, non-C hepatitis Nihon Rinsho. Japanese Journal of Clinical Medicine 55(3): 559-563